Pernix Thera rescues struggling Somaxon with stock deal worth $25 million
05:01 EST 12 Dec 2012 | thePharmaLetter
Troubled US drugmaker Somaxon Pharmaceuticals (Nasdaq: SOMX) saw its shares leap around 85% to $2.74 yesterday morning, when it was revealed that fellow USA-based Pernix Therapeutics (NYSE: PTX) had agreed a merger accord in a stock-for-stock transac..
Original Article: Pernix Thera rescues struggling Somaxon with stock deal worth $25 million
More From BioPortfolio on "Pernix Thera rescues struggling Somaxon with stock deal worth $25 million"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
